Bright Minds Biosciences DRUG
NASDAQ DRUG
$67.60 -0.42 (-0.62%)
As of: Sep 4, 2026 · 12:42 PM EDT

Bright Minds Biosciences (DRUG) Shares Outstanding (Entity) (2019 - 2025)

Analysis

Bright Minds Biosciences (DRUG) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 214.24 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 575.00 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 218.28 Mn
10 Bright Minds Biosciences 464.96 Mn 242.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 7.64 Mn
Sep 30, 2024 4.52 Mn
Sep 30, 2023 3.72 Mn
Sep 30, 2022 2.47 Mn
Sep 30, 2021 1.79 Mn
Sep 30, 2020 722,487.00
Sep 30, 2019 414,648.00